Low risk — use of or exposure to this product is not likely to cause adverse health consequences.
Estradiol 12.5 mg Pellet Recalled by Wells Pharmacy Network, LLC Due to Superpotent and Subpotent drugs
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Wells Pharmacy Network, LLC directly.
Affected Products
Estradiol 12.5 mg Pellet, Compounded by: Wells Pharmacy Network
Quantity: 353 pellets
Why Was This Recalled?
Superpotent and Subpotent drugs
Where Was This Sold?
U.S.
About Wells Pharmacy Network, LLC
Wells Pharmacy Network, LLC has 7 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report